Latest News

Friday, February 12, 2016 | Management/Leadership

LensGen Adds Two Prominent Ophthalmic Surgeons to its Scientific Advisory Board

LensGen, an Irvine, California-based company that has a novel curvature-changing accommodating IOL in clinical development, announced that Eric Donnenfeld, MD, and Rosa Braga-Mele, MD, FRCSC, have joi…

Read the full story

Friday, February 12, 2016 | FDA Approval/Clearance, Optovue

Optovue’s AngioVue Imaging System Receives FDA Clearance

Optovue announced FDA clearance and immediate US commercial availability of the AngioVue Imaging System, which provides a non-invasive way to visualize abnormal blood vessels in the retina to help phy…

Read the full story

Friday, February 12, 2016 | Product Releases

D-EYE Srl RD-EYE Srl Raises 1.5 Million Euros to Launch Its Smartphone-Based Retinal Imaging System

D-EYE Srl announced that it has received seed funding from Innogest, Invitalia Ventures Giuseppe e Annamaria Conttino Foundation, and Si14 Spa, to advance the company's mobile device hardware and …

Read the full story

Friday, February 12, 2016 | Medical Studies

Biggest Ever Infectious Disease Survey to Speed End of Trachoma

Surveyors were taken hostage in Yemen, accused of being representatives of Dracula in Papua New Guinea, worked in sandstorms and temperatures of 50 degrees Celsius (122 degrees Fahrenheit) in Ethiopia…

Read the full story

Thursday, February 11, 2016 | Medical Studies

Study Examines Zika Virus Infection and the Eye

Human and insect travel between continents has resulted in the dissemination of previously remote infections to more populated parts of the world. West Nile virus apparently moved from Israel to N…

Read the full story

Thursday, February 11, 2016 | Retina, ONL Therapeutics

ONL Therapeutics Receives Orphan Drug Designation from FDA for ONL1204 for Treatment of Retinal Detachment

ONL Therapeutics announced that the FDA has granted orphan drug designation to ONL1204 for the treatment of retinal detachment, according to a company news release. ONL1204 is a novel, first-in-class …

Read the full story

Thursday, February 11, 2016 | Product Releases, Haag Streit

Haag-Streit Introduces MASK-it Eye Patch

Haag-Streit has announced the launch of the convenient MASK-it eye patches as an addition to their Octopus product range. The MASK-it eye patches are the first disposable eye patches for perimet…

Read the full story

Thursday, February 11, 2016 | Clinical Trials, Aerpio Therapeutics

Aerpio Therapeutics Announces Presentation of Positive Results of AKB-9778 in Patients with Diabetic Retinopathy from TIME-2 Phase 2a Study

Aerpio Therapeutics announced promising results in diabetic retinopathy from the company’s phase 2a study (TIME-2) of its lead candidate, AKB-9778, a first-in-class Tie2 activator, according to …

Read the full story

Wednesday, February 10, 2016 | Medical Studies

Keep an Eye Out For Ocular Syphilis

The Centers for Disease Control and Prevention (CDC) is seeing an increase in reports of ocular syphilis, and this diagnosis should be on every clinician's radar. Ocular syphilis is a clinical man…

Read the full story

Wednesday, February 10, 2016 | Medical Studies

Medscape: The 50 Most Influential Physicians in History, Part 1: #50-#36

Compiling a ranking of the most influential physicians throughout history is a perilous undertaking that has fueled animated discussions between Medscape editors and advisors. Influence is a tricky th…

Read the full story

Tuesday, February 09, 2016 | Partnerships, Second Sight Medical Products

Second Sight Announces Exclusive Agreement with Tecnosalud to Bring the Argus II Retinal Prosthesis to Argentina

Second Sight Medical Products announced plans to expand into South America by signing an exclusive agreement with Tecnosalud to distribute the Argus II Retinal Prosthesis System in Argentina, accordin…

Read the full story

Tuesday, February 09, 2016 | Partnerships, STAAR Surgical

Staar Surgical and Memira Holding Announce Cooperation Agreement for Memira's Eye Clinics Throughout Scandinavia

Staar Surgical and Memira Holding, Sweden, announced they have entered into an agreement effective January 1, 2016, to provide STAAR's phakic intraocular lenses (ICL) as a primary and premium opti…

Read the full story

Tuesday, February 09, 2016 | Clinical Trials, SalutarisMD

SalutarisMD Clinical Results Presented at World Ophthalmology Congress

This week, Salutaris Medical Devices investigational therapy for wet AMD was featured at the World Ophthalmology Congress in two scientific poster presentations by Kamaljit Balaggan, MD. Dr. Balaggan …

Read the full story

Tuesday, February 09, 2016 | Medical Studies

Mitochondrial Replacement 'Ethically Permissible,' IOM Says

A new consensus report issued by the Institute of Medicine finds that research into mitochondrial replacement techniques (MRTs), where an embryo has genetic information from three people, is "eth…

Read the full story

Monday, February 08, 2016 | Acquisitions/Mergers, Allergan

Pfizer Names Executive Leadership Team for Combined Organization Upon Close of Proposed Allergan Transaction

Pfizer announced the executive leadership team for the combined Pfizer and Allergan business following the close of the proposed transaction. As previously announced, following the closing, Brent Saun…

Read the full story
Load More
 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $13.75  0.00% 
 Akorn, Inc. $23.96  0.00% 
 Alimera Sciences, Inc. $2.15  0.00% 
 Allergan $280.48  0.00% 
 Avalanche Biotechnologies $4.80  0.00% 
 Bayer $106.92  0.00% 
 Can-Fite Biopharma $2.05  0.00% 
 Carl Zeiss Meditec $26.22  0.00% 
 Cooper Companies, Inc. $133.58  0.00% 
 Eleven Biotherapeutics $0.27  0.00% 
 Escalon Medical Corp. $0.87  0.00% 
 Essilor International $123.45  0.00% 
 Glaukos $15.36  0.00% 
 Imprimis Pharmaceuticals, Inc. $4.10  0.00% 
 Inotek Pharmaceuticals $6.67  0.00% 
 InSite Vision, Inc. $0.35  0.00% 
 IRIDEX Corporation $9.24  0.00% 
 Johnson & Johnson $101.82  0.00% 
 Luxottica Group, S.p.A. $56.50  0.00% 
 Merck & Company, Inc. $49.03  0.00% 
 NicOx $6.40  0.00% 
 NovaBay Pharmaceuticals, Inc. $2.01  0.00% 
 Novartis AG Common Stock $72.70  0.00% 
 Ocular Therapeutix $5.59  0.00% 
 Ophthotech Corporation $47.47  0.00% 
 QLT $2.46  0.00% 
 Quantel $2.76  0.00% 
 Regeneron $379.01  0.00% 
 Roche $31.27  0.00% 
 Second Sight Medical Products $4.13  0.00% 
 Shire $159.90  0.00% 
 STAAR Surgical Company $6.28  0.00% 
 TearLab Corporation $0.92  0.00% 
 Thrombogenics $3.13  0.00% 
 Topcon Corporation $10.98  0.00% 
 Valeant Pharmaceuticals $88.39  0.00% 
 Xoma $0.77  0.00%